Zeidner, Joshua F <br/><br/>
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia.  [electronic resource] 

 -  Haematologica  Sep 2015 
 - 1172-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2015.125849  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Flavonoids--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Leukemia, Myeloid, Acute--diagnosis<br/>Male<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Piperidines--administration & dosage<br/>Survival Rate